ReviewNanomedicine (London, England)2013
Multiplexed detection of molecular biomarkers with phase-change nanoparticles.
Review in Nanomedicine (London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
This review describes a new biosensing method based on nanoparticles of solid-to-liquid phase-change materials, in which a panel of metallic nanoparticles (metals and eutectic alloys) that have different compositions and melting temperatures are used as thermal reporters. Each type of nanoparticle will be conjugated to a ligand that can specifically bind to one type of molecular biomarker (protein or DNA) and then immobilized onto a substrate that is comodified with multiple ligands by forming sandwiched antibody-antigen complexes or DNA double helices. After removing unbound nanoparticles by washing, the nature and concentration of the biomarkers are determined by detecting the melting temperature and fusion enthalpy of the nanoparticles using differential scanning calorimetry. Furthermore, an even larger panel of thermal barcodes can be formed by encapsulating selected phase-change nanoparticles inside non-melting shells, such as silica, where each microparticle will have a characteristic signature that can be determined from its thermal signatures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.